Literature DB >> 450165

Differential effects of diuretic agents on electrolyte excretion in the dog. Role of renal hemodynamics.

J B Puschett, M A Kuhrman.   

Abstract

The sulfonamide derivative diuretics acetazolamide, metolazone and furosemide produce differing degrees of natriuresis and varying patterns of phosphate excretion. At least part of the explanation for these diverse actions could be related to divergent effects of the drugs on total renal blood flow (TRBF) and its intracortical distribution (IBFD). To test this hypothesis, and to determine if a consistent thesis regarding alterations in interenal blood flow could be developed, clearance studies were performed in chronically thyroparathyroidectomized dogs in which radioactive microsphere methodology was utilized to evaluate the distribution of blood flow within the renal cortex. These data were then compared with those available in the literature. The variations which the drugs induced in TRBF and IBFD did not help to explain the differences in their diuretic actions. However, a consistent hypothesis relating natriuresis, perfusion pressure, renal vascular resistance, TRBF and IBFD could be developed based on the data from this study and those available in the literature.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 450165     DOI: 10.1159/000181604

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  3 in total

1.  The effect of a natriuretic atrial extract on renal haemodynamics and urinary excretion in anaesthetized rats.

Authors:  H B Borenstein; W A Cupples; H Sonnenberg; A T Veress
Journal:  J Physiol       Date:  1983-01       Impact factor: 5.182

Review 2.  Renal handling of calcium and phosphate.

Authors:  F Lang
Journal:  Klin Wochenschr       Date:  1980-10-01

3.  Dopamine-induced diuresis in the cat without changes in renal hemodynamics.

Authors:  K Wassermann; R Huss; R Kullmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-05       Impact factor: 3.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.